SCHEMBL367620

SCHEMBL367620

[C]1=CC=CC2C=Cc3ccccc3NC12

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445110 0.74 GAA (0.34) GAAMAPT
SCHEMBL3118101 0.73 GAA (0.39) GAAMAPT
SCHEMBL367177 0.65 GAA (0.34) GAAMAPT
SCHEMBL365987 0.65 GAA (0.34) GAAMAPT
SCHEMBL4540870 0.64 GAA (0.44) GAAMAPT
SCHEMBL18562457 0.64 GAA (0.44) GAAMAPT
SCHEMBL6056252 0.64 GAA (0.44) GAAMAPT
SCHEMBL4283708 0.64 GAA (0.44) GAAMAPT
SCHEMBL12159337 0.64 GAA (0.44) GAAMAPT
SCHEMBL6111309 0.64 GAA (0.44) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392168-A1 IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS The Regents of the University of Colorado, a body corporate (US) 2024-07-03 EP disclosed
EP-4392075-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS Yale University (US) 2024-07-03 EP disclosed
WO-2024081715-A2 LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-04-18 WO disclosed
WO-2023028323-A9 IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2024-04-04 WO disclosed
WO-2022178428-A9 TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME YALE UNIVERSITY (US) 2023-08-17 WO disclosed
EP-4216949-A1 SELECTIVE AGONISTS OF 5-HT2A RECEPTOR AND METHODS OF USE Yale University (US) 2023-08-02 EP disclosed
EP-4168499-A1 METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS The Regents of the University of Colorado, a body corporate (US) 2023-04-26 EP disclosed
WO-2023056282-A1 COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2023-04-06 WO disclosed
WO-2023028323-A1 IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-03-02 WO disclosed
WO-2023028597-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY (US) 2023-03-02 WO disclosed
WO-2009017954-A1 INHIBITORS OF JAK2 KINASE PHENOMIX CORPORATION (US) 2009-02-05 WO disclosed
WO-2008107362-A2 STABILISER AND INHIBITORS OF FACTOR VII NOVO NORDISK HEALTH CARE AG (DK) 2008-09-12 WO disclosed
WO-2008107363-A1 NEW BLOOD COAGULATION FACTOR INHIBITORS NOVO NORDISK HEALTH CARE AG (DK) 2008-09-12 WO disclosed
WO-2008086161-A1 MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS PHENOMIX CORPORATION (US) 2008-07-17 WO disclosed
EP-1919485-A1 METHODS OF PREPARING HETERCYCLIC BORONIC ACIDS AND DERIVATIVES THEREOF Phenomix Corporation (US) 2008-05-14 EP disclosed
WO-2007016356-A1 METHODS OF PREPARING HETERCYCLIC BORONIC ACIDS AND DERIVATIVES THEREOF PHENOMIX CORPORATION (US) 2007-02-08 WO disclosed
EP-1689757-A4 HETEROCYCLIC BORONIC ACID COMPOUNDS PHENOMIX CORP (US) 2007-01-10 EP disclosed
EP-1689757-A1 HETEROCYCLIC BORONIC ACID COMPOUNDS Phenomix Corporation (US) 2006-08-16 EP disclosed
WO-2005047297-A1 HETEROCYCLIC BORONIC ACID COMPOUNDS PHENOMIX CORPORATION (US) 2005-05-26 WO disclosed
WO-2002071844-A1 HETEROCYCLIC HYDROXAMIC ACID DERIVATIVES AS MMP INHIBITORS ADVANCED SYNTECH, LLC A KENUCKY LIMITED LIABILITY CORPORATION (US) 2002-09-19 WO disclosed